why choose us

Clinical Trials Search

Showing 7,770 of 132,963 result(s)
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

Status: Completed

Condition: Non-Small Cell Lung Cancer

Interventions: Fixed dose coformulated product of hyaluronidase;pembrolizumab adminstered via SC injection.

Date: 2023-10-19

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Status: NOT_YET_RECRUITING

Condition: Advanced Melanoma

Interventions: Soluble PRAME-specific T cell receptor with anti-CD3 scFV concentrate for solution for intravenous (IV) infusion at a unit dose of 0.2 mg;mL.

Date: 2023-10-19

Controlled Arterial Protection to Ultimately Remove Embolic Material

Status: NOT_YET_RECRUITING

Condition: Aortic Valve Stenosis

Interventions: The EmStop Embolic Protection System (EmStop System) is a catheter-based filter system that captures and removes debris dislodged during transcatheter

Date: 2023-10-19

Yoga Training and Retinal Vasculature

Status: Completed

Condition: Cognitive Change

Interventions: Participants in this group will receive high-speed yoga with cuing 3 times per week for 24 consecutive weeks for a total of 72 training sessions of 1

Date: 2023-10-19

Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients

Status: NOT_YET_RECRUITING

Condition: Diabetic Kidney Disease

Interventions: Soleus muscle exercise before and after eating by half an hour

Date: 2023-10-19

Study on Regulated Cannabis Sales in Pharmacies

Status: NOT_YET_RECRUITING

Condition: Marijuana Smoking

Interventions:

The intervention group is allowed to purchase regulated cannabis in authorized pharmacies.
The intervention includes various offers: Participa

Date: 2023-10-19

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

Status: Completed

Condition: Hepatocellular Carcinoma

Interventions: Atezolizumab will be administered at a dose of 1200 mg by IV infusion on Day 1 of each 21-day cycle.

Date: 2023-10-18

Self-Administered 2-Hour Oral Glucose Tolerance Test

Status: Completed

Condition: Gestational Diabetes

Interventions: Participants will be asked to self-administer the postpartum 75-gram oral glucose tolerance test.
They will be provided the glucose solution and

Date: 2023-10-18

Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients

Status: NOT_YET_RECRUITING

Condition: Hemiplegic Shoulder Pain

Interventions: This study will be using osteopathic manual therapy as the primary intervention.
Osteopathic manual therapy (OMT) is a hands-on treatment that is

Date: 2023-10-18

Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1

Status: NOT_YET_RECRUITING

Condition: Heart Failure

Interventions: Monthly email containing information including their total medication titration encounters over a 3 month period, as well as the site and VISN level f

Date: 2023-10-18